Cargando…
Do co-morbidities, frailty and functional status identify patients who may not benefit from ICD therapy?
FUNDING ACKNOWLEDGEMENTS: Type of funding sources: Private grant(s) and/or Sponsorship. Main funding source(s): Boston Scientific ISR lite. BACKGROUND: In carefully selected patients, Implantable Cardioverter Defibrillators reduce all-cause mortality by reducing the burden of sudden cardiac death. M...
Autores principales: | Wilson, D G, James, S X, Power, D F, Sharma-Oates, A, Lord, J M, Roberts, P R, Morgan, J M |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10207408/ http://dx.doi.org/10.1093/europace/euad122.416 |
Ejemplares similares
-
ICD patients with first appropriate ICD shock: new treatment concept is associated with better outcome
por: Kleemann, T, et al.
Publicado: (2023) -
Subcutaneous ICD therapy results in a similar quality of life compared with transvenous ICD therapy during both short- and long-term follow-up
por: De Veld, J A, et al.
Publicado: (2023) -
Quality improvements anticipated by guideline adherence to peri-operative ICD deactivation
por: Finnerty, D, et al.
Publicado: (2023) -
Clinical predictors of very low defibrillation threshold in the extravascular ICD
por: Murgatroyd, F, et al.
Publicado: (2023) -
Capsulectomy: a safe and effective way to lower shock impedance in S-ICD replacement procedures
por: Wuerfel, S, et al.
Publicado: (2023)